Jon C. Ogg - Author for 24/7 Wall St.
Lastest Stories by Jon C. Ogg
Warren Buffett may be getting older every year, but he and the giant Berkshire Hathaway have remained acquirers of public stocks for years. The conglomerate could even claim to be one of the largest...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included AGCO, Apple, Caterpillar, Cisco Systems, Deere, Evergy, Levi Strauss, Paypal, Slack and Urban Outfitters.
Published:
Last Updated:
The economy that is effectively the linchpin of the European Union just reported that its GDP was lower in the second quarter. Some economists may now treat Germany as though it is in a technical...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations for Wednesday included Acorda Therapeutics, Activision Blizzard, Bloom Energy, Care.com, CBS, Deere and Ferrari.
Published:
Last Updated:
24/7 Wall St. wanted to review the top oil and gas stocks by market cap to see if there are any opportunities at all.
Published:
Last Updated:
Barrick Gold has already risen handily in 2019, but the independent research firm Argus now sees its stock rising much higher based on costs, gold prices, and merger benefits all driving stronger...
Published:
Last Updated:
The reaction in Argentina's top stocks to Argentinian President Mauricio Macri losing a primary election was worse than atrocious. It was a bloodbath.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations on Tuesday included Advanced Micro Devices, Apple, Barrick Gold, Domino's Pizza, Intel, McDonald's, Occidental Petroleum and Salesforce.com.
Published:
Last Updated:
To hear market pundits talk up the future of India, it might seem as though the future is bright and that there aren't any dark clouds. Those who have invested in India over the years might have a...
Published:
Last Updated:
In the argument about who pays for negative interest rates, there may be no winners. It still looks like the odds of negative interest rates in the United States appear to be less than zero.
Published:
Last Updated:
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
Published:
Last Updated:
Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against which short sellers are betting the farm.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations on Monday included Bluebird Bio, Genmab, GTT Communications, Humana, National Oilwell Varco, News Corp., ONEOK, Symantec and Uber Technologies.
Published:
Last Updated:
Despite a trade war with China and a slowing economy, some companies are seriously kicking butt and taking names when they report earnings. If earnings are the true ultimate driver of share prices...
Published:
Last Updated: